Paul J. Catalano

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 2.3K citations

Medicine, Oncology, Pharmacotherapy +15

Colon Cancer Survival Is Associated With Increasing Number of Lymph Nodes Analyzed: A Secondary Survey of Intergroup Trial INT-0089

Thomas E. Le Voyer, Elin R. Sigurdson, Alexandra L. Hanlon et al. · Journal of Clinical Oncology · 2003 · 1.2K citations

Medicine, Oncology, Surgery +17

Patients' Expectations about Effects of Chemotherapy for Advanced Cancer

Jane C. Weeks, Paul J. Catalano, Angel M. Cronin et al. · New England Journal of Medicine · 2012 · 1.2K citations · Full text

Medicine, Oncology, Chemotherapy +12

Molecular Predictors of Survival after Adjuvant Chemotherapy for Colon Cancer

Toshiaki Watanabe, Tsung‐Teh Wu, Paul J. Catalano et al. · New England Journal of Medicine · 2001 · 895 citations · Full text

Medicine, Molecular Medicine, Oncology +14

Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study

Daniel Cagney, Allison Martin, Paul J. Catalano et al. · Neuro-Oncology · 2017 · 838 citations · Full text

Medicine, Biostatistics, Oncology +10